Clinical trial
The Effects of Eicosapentaenoic Acid (EPA), Gamma-Linolenic Acid (GLA) and…
NCT00329680 · Fernandes Tavora Hospital, Other · Completed
Key facts
| NCT number | NCT00329680 |
|---|---|
| Title | The Effects of Eicosapentaenoic Acid (EPA), Gamma-Linolenic Acid (GLA) and Antioxidants in the Treatment of Sepsis |
| Official title | Investigating Nutritional Therapy With EPA, GLA and Antioxidants Role in Sepsis Treatment-INTERSEPT STUDY |
| Lead sponsor | Fernandes Tavora Hospital, Other |
| Collaborators | Abbott Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Sepsis, Severe Sepsis, Septic Shock |
| Intervention type | Dietary Supplement |
| Interventions | Eicosapentaenoic acid, Gamma-Linolenic Acid and Antioxidant Vitamins, Standard ICU enteral diet, isocaloric to the study diet |
| Enrollment | 115 |
| Start date | Jun 1, 2007 |
| Primary completion | Dec 1, 2008 |
| Completion | Oct 1, 2009 |
| First posted | May 25, 2006 |
| Last update posted | Dec 31, 2009 |
| Countries | Brazil |
At a glance
- 10–99 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: